NASDAQ · Airlines, Airports & Air Services
Strata Critical Medical, Inc. (SRTA) Stock
$4.47
-4.49%
NASDAQ: SRTA
Industrials
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call
GlobeNewswire · Jul 21, 2026
Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
GlobeNewswire · Jun 24, 2026
Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?
Zacks · Jun 16, 2026
Strata Critical Medical Acquires Louisville Perfusion Services
MT Newswires · Jun 2, 2026
Strata Acquires Louisville Perfusion Services
GlobeNewswire · Jun 2, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held13.80%
Institutions Held69.96%
Institutions Float Held81.16%
Peer Comparison
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. is led by CEO Melissa Tomkiel, employs 310 people, headquartered in US, publicly traded since 2019.
Strata Critical Medical, Inc. (SRTA) stock trades at $4.47 with a market capitalization of $386.77M. The stock is valued at a price-to-earnings (P/E) ratio of 9.47, price-to-book of 1.46, price-to-sales of 1.60. Over the past 52 weeks the stock has ranged between $3.95 and $6.50, and currently trades 31.2% below its 52-week high.
On profitability, Strata Critical Medical, Inc. generates a return on equity (ROE) of 14.27%, above the typical market average, return on capital employed of -7.11%, an operating margin of -5.08%, a net profit margin of 15.71%.